Logo

OncoBlast-GU Oncology II

This CME-accredited activity, GU Oncology 2, is designed to improve the care of GU patients by educating clinicians involved in cancer care. This activity is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care of GU Cancers

Course Accreditations

Course Summary

Events StartsEvents Ends
1/1/202512/31/2025

Faculty

Mamta Parikh   (MD)

Dr. Parikh is a medical oncologist who divides her time between patient care, clinical research and education. She is the Medical Director of Genitourinary Malignancies at the UC Davis Comprehensive Cancer Center, and develops investigator-initiated trials in addition to participation of NCTN and ETCTN consortia. She is also dedicated to research education for medical students.

Disclosure
Financial relationships Yes, I have had a financial relationship with an ineligible company within the past 24 months. Financial relationships: Attribution: Self Type of financial relationship: Other Ineligible company: Pfizer Topic: Consulting Relationship end date: 08/31/2024 Attribution: Self Type of financial relationship: Other Ineligible company: Bristol Myers Squibb Topic: Advisory Board Relationship end date: 04/19/2024 Attribution: Self Type of financial relationship: Other Ineligible company: Sanofi Aventis Topic: Advisory Board Relationship end date: 06/20/2023 Attribution: Self Type of financial relationship: Other Ineligible company: Karyopharm Topic: Research Support Relationship end date: 01/01/2024 Attribution: Self Type of financial relationship: Other Ineligible company: Gilead Topic: Research Support
top-curriculum

    Target Audience

  • Medical oncologists
  • Radiation oncologists
  • Surgical oncologists
  • Oncology residents/fellows
  • Oncology NPs/PAs
  • Oncology pharmacists
  • Oncology nurses

    Learning Objectives

    Upon successful completion of this educational activity, participants will be able to:

  • Discuss new and updated treatment options for patients with GU Cancers
  • Identify side effects, indications, and contra-indications of therapies used to diagnose and treat GU Cancers
  • Explain how to effectively manage side-effects associated with GU Cancer treatment